Skip to content
Myriad Women's Health Blog

Myriad Women's Health Blog

  • Home
  • Clinical
  • Patients
  • News
  • Counsyl Complete
  • My Twitter Profile
  • My LinkedIn Profile
clinical Genomics and Genetic Counseling Patients Product Reproductive Health

Three words that changed my life

By CounsylMarch 26, 2018May 29, 2018
Continue Reading
Genomics and Genetic Counseling Patients Product Reproductive Health

Rare Disease Day Q&A with Karen Haberberg

By CounsylMarch 19, 2018March 19, 2018
Continue Reading
Counsyl Culture Events News

Counsyl celebrates International Women’s Day

By CounsylMarch 8, 2018March 8, 2018
Continue Reading
Counsyl Complete Counsyl Culture Genomics and Genetic Counseling News Patients Product

Introducing the new counsyl.com

By CounsylMarch 2, 2018May 29, 2018
Continue Reading
clinical Counsyl Complete Counsyl Culture Events News Patients Product Reproductive Health

We’ve delivered our one millionth screen

By CounsylJanuary 30, 2018
Continue Reading
clinical News Patients Product Reproductive Health

Counsyl Secures Approval from New York State Department of Health for Prelude™ Prenatal Screen

By CounsylJanuary 16, 2018April 4, 2018
Continue Reading

Posts navigation

Older posts
Newer posts

Myriad Women's Health Blog

  • My Twitter Profile
  • My LinkedIn Profile

About us

Counsyl’s mission is to improve lives by providing actionable information that guides women and their families in making critical and timely health decisions. We seek to transform the execution and delivery of complex genetic testing through our three high-value screens and comprehensive suite of end-to-end workflow solutions for healthcare providers.

Counsyl is a trademark of Myriad Women’s Health, Inc. Copyright © Myriad Women’s Health, Inc. All rights reserved.

Learn more about Counsyl

  • www.counsyl.com
  • Foresight Carrier Screen
  • Prelude Prenatal Screen
  • Reliant Cancer Screen

Subscribe to receive news from Counsyl

Subscribe to our newsletter